metoclopramide has been researched along with Cancer of Head in 12 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoclopramide (MCP) was given i." | 6.65 | Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984) |
| "Metoclopramide (MCP) was given i." | 2.65 | Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984) |
| "Intradermally injected human squamous cell carcinoma cells were grown to 40 to 80 mm3 in athymic nude mice and irradiated with 675-nm light (75 J/cm2, 75 mW/cm2) 24 hours after the intraperitoneal injection of SiPc IV (1." | 1.29 | Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck. ( Antunez, AR; Jafri, A; Megerian, CA; Stepnick, DW; Werning, JW; Zaidi, SI, 1995) |
| "Two human squamous cell carcinoma lines of the head and neck xenografted to nude mice have been used." | 1.28 | Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck. ( Kjellén, E; Lybak, S; Pero, R; Wennerberg, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cognetti, F | 1 |
| Pinnarò, P | 1 |
| Carlini, P | 1 |
| Conti, EM | 1 |
| Cortese, M | 1 |
| Pollera, CF | 1 |
| Werning, JW | 1 |
| Stepnick, DW | 1 |
| Jafri, A | 1 |
| Megerian, CA | 1 |
| Antunez, AR | 1 |
| Zaidi, SI | 1 |
| Sugasawa, M | 1 |
| Nibu, K | 1 |
| Ichimura, K | 1 |
| Kaga, K | 1 |
| Asai, M | 1 |
| Senba, T | 1 |
| Yamasoba, T | 1 |
| Tsunoda, K | 1 |
| Abe, K | 1 |
| Kobayashi, T | 1 |
| Saunders, MI | 1 |
| Hoskin, PJ | 1 |
| Pigott, K | 1 |
| Powell, ME | 1 |
| Goodchild, K | 1 |
| Dische, S | 1 |
| Denekamp, J | 1 |
| Stratford, MR | 1 |
| Dennis, MF | 1 |
| Rojas, AM | 1 |
| Lybak, S | 2 |
| Wennerberg, J | 3 |
| Kjellén, E | 3 |
| Pero, RW | 1 |
| Roila, F | 1 |
| Basurto, C | 1 |
| Bracarda, S | 1 |
| Picciafuoco, M | 1 |
| Ballatori, E | 1 |
| Del Favero, A | 1 |
| Tonato, M | 1 |
| El-Sayed, S | 1 |
| Symonds, RP | 1 |
| Robertson, AG | 1 |
| Paul, J | 1 |
| McGarva, J | 1 |
| Pero, R | 2 |
| Rosenblatt, E | 1 |
| Lev, LM | 1 |
| Robinson, E | 1 |
| Saller, R | 2 |
| Hellenbrecht, D | 2 |
6 trials available for metoclopramide and Cancer of Head
| Article | Year |
|---|---|
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cl | 1984 |
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
Topics: Administration, Oral; Aerosols; Antiemetics; Carbon Dioxide; Disease-Free Survival; Dose Fractionati | 1997 |
Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 1990 |
High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; | 1988 |
High doses of metoclopramide or droperidol in the prevention of cisplatin-induced emesis.
Topics: Cisplatin; Clinical Trials as Topic; Droperidol; Head and Neck Neoplasms; Humans; Lung Neoplasms; Ma | 1986 |
Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Topics: Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Drug Administrat | 1985 |
6 other studies available for metoclopramide and Cancer of Head
| Article | Year |
|---|---|
Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, D | 1995 |
[Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 1994 |
Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck.
Topics: Animals; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Drug Therapy, Combination | 1991 |
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diphenhydramine; Drug Eval | 1990 |
Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck.
Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Head and Neck Neop | 1990 |
Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female | 1989 |